News Daily News Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force Michael O'Riordan October 11, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017